Insiders Updates BofA Securities gives a Neutral recommendation for Keros Therapeutics Inc (KROS) Keros Therapeutics Inc’s filing revealed that its 10% Owner ADAR1 Capital Management, LLC acquired Company’s shares for reported $9.46 million
Analysts Viewpoint 10% Owner ADAR1 Capital Management, LLC acquire 934,258 shares of Keros Therapeutics Inc [KROS] Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Analysts Viewpoint Keros Therapeutics Inc [KROS] 10% Owner makes an insider purchase of 934,258 shares worth 9.46 million. Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Analysts Viewpoint Analysts review Keros Therapeutics Inc’s rating Keros Therapeutics Inc’s filing revealed that its 10% Owner ADAR1 Capital Management, LLC acquired Company’s shares for reported $9.46 million